Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
MSFT -7.97META 2.815BKNG 0.45HMP.TO 0SPGP 0.19ZUQ.TO -0.34NVDA -3.89GL 0.93
Valeant Pharmaceuticals (VRX.TO)

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Valeant Pharmaceuticals(VRX.TO)

Feb 04, 2002
Good products/prospects. Expensive.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$71.35

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 30, 2002
Could drop to $50.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$72.46

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 28, 2002
Expects the shorts will make it very volatile.
Photo of Arthur HeinmaaArthur HeinmaaUnlock Rating
$76.94

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 24, 2002
Seems to have acquired some problems and no one seems to know what they are. Speculative now.
Photo of Brendan KyneBrendan KyneUnlock Rating
$81.60

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 24, 2002
Management is trying to paint too rosy a picture.
Photo of Andrew CookAndrew CookUnlock Rating
$81.60

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 22, 2002
Some stable growth and can see a lot of upside. Not cheap.
Photo of John ZechnerJohn ZechnerUnlock Rating
$86.00

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 15, 2002
A little too high now, but a good company.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$82.86

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jan 07, 2002
Good sales will continue to grow. 30% annual growth. Very solid.
Photo of Gordon Higgins, CA, MBAGordon Higgins, CA, MBAUnlock Rating
$87.00

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jan 03, 2002
Large pharmaceuticals will have to buy some biotechs to keep their pipelines growing, so a possible takeover.
Photo of Joe ConnollyJoe ConnollyUnlock Rating
$86.75

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Dec 10, 2001
Good product. Will grow 60% this year and 30% annually over the next 2 years.
Photo of David BurrowsDavid BurrowsUnlock Rating
$85.41

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Dec 06, 2001
Shifting from generic to proprietary drugs. A good value.
Photo of Ted MacklinTed MacklinUnlock Rating
$86.00

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Nov 26, 2001
A lot of cash. Great performance.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$84.97

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Oct 22, 2001
Likes.
Photo of Ted MacklinTed MacklinUnlock Rating
$77.00

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Sep 24, 2001
At a good price.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$62.70

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Sep 10, 2001
Has a good number of products. A safe way of playing biotechs. Good mngmnt.
Photo of Nereo PiticcoNereo PiticcoUnlock Rating
$70.05

Stock price when the opinion was issued

Healthcare
Showing 661 to 675 of 714 entries
The ultimate 360° Tracker Your financial life in one place, automatically

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

FCX -0.2$69.93
MU -41.09$1046.9
WDC 45.93$699.46
AAPL 2.53$298.95
SPCX 23.15$215.65

Today's Top Picks

MSFT -7.97$391.79
META 2.815$596.295
BKNG 0.45$175.09
HMP.TO 0$9.76
SPGP 0.19$121.79

Popular Articles

Latest Sell Signals

CRWD -11.56$681.35
MSFT -7.97$391.79
SCCO -0.2$193.02
ADBE 1.82$208.18
PEP 0.195$146.445

Most Recent Experts

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica